Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults

被引：0

作者：

Jean-Yves Reginster

Charlotte Beaudart

Nasser Al-Daghri

Bernard Avouac

Jürgen Bauer

Nathalie Bere

Olivier Bruyère

Francesca Cerreta

Matteo Cesari

Mario Miguel Rosa

Cyrus Cooper

Alfonso J. Cruz Jentoft

Elaine Dennison

Anton Geerinck

Evelien Gielen

Francesco Landi

Andrea Laslop

Stefania Maggi

María Concepción Prieto Yerro

René Rizzoli

Hildrun Sundseth

Cornel Sieber

Andrea Trombetti

Bruno Vellas

Nicola Veronese

Marjolein Visser

Mila Vlaskovska

Roger A. Fielding

机构：

[1] University of Liège,WHO Collaborating Center for Public Health Aspects of Musculo

[2] King Saud University,Skeletal Health and Ageing, Division of Public Health, Epidemiology and Health Economics

[3] CHU Henri Mondor,Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science

[4] Heidelberg University,Department of Rheumatology

[5] European Medicines Agency,Center for Geriatric Medicine and Network Aging Research

[6] University of Milan,Department of Clinical Sciences and Community Health

[7] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Geriatric Unit

[8] Faculdade de Medicina da Universidade de Lisboa,Departamento de Neurociências/Laboratório de Farmacologia Clínica E Terapêutica

[9] University of Southampton,MRC Lifecourse Epidemiology Unit

[10] Hospital Universitario Ramón Y Cajal (IRYCIS),Division of Geriatrics

[11] UZ Leuven,Department of Geriatrics, Neurosciences and Orthopedics

[12] Catholic University of the Sacred Heart Rome,Scientific Office

[13] Federal Office for Safety in Health Care,Division of Bone Diseases

[14] CNR Aging Branch-IN,Department of Internal and Geriatrics Medicine, Gerontopole, CHU de Toulouse, UMR 1027 INSERM

[15] Agencia Española de Medicamentos Y Productos Sanitarios,Department of Internal Medicine, Geriatrics Section

[16] Geneva University Hospitals and Faculty of Medicine,Department of Health Sciences

[17] European Institute of Women’s Health,Medical Faculty, Department of Pharmacology and Toxicology

[18] Institute for Biomedicine of Aging Friedrich-Alexander University Erlangen-Nürnberg,Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center On Aging

[19] University Toulouse III,Gerontology and Geriatrics, Department of Public Health and Primary Care

[20] University of Palermo,undefined

[21] Vrije Universiteit Amsterdam,undefined

[22] Medical University Sofia,undefined

[23] Tufts University,undefined

[24] KU Leuven,undefined

[25] Kantonsspital Winterthur,undefined

来源：

Aging Clinical and Experimental Research | 2021年 / 33卷

关键词：

Clinical trial; Sarcopenia; Guidelines; Recommendations; Drug registration; Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3 / 17

页数：14

共 50 条

[41] Attitudes of Older Adults to Their Participation in Clinical Trials: A Pilot Study
Frédéric Bloch
Nathalie Charasz
[J]. Drugs & Aging, 2014, 31 : 373 - 377
[42] Representative enrolment of older adults in clinical trials: the time is now
Schwartz, Janice B.
[J]. LANCET HEALTHY LONGEVITY, 2023, 4 (07): : 301 - 303
[43] Attitudes of Older Adults to Their Participation in Clinical Trials: A Pilot Study
Bloch, Frederic
Charasz, Nathalie
[J]. DRUGS & AGING, 2014, 31 (05) : 373 - 377
[44] Exclusion of Older Adults in COVID-19 Clinical Trials
Jaoude, Joseph Abi
Kouzy, Ramez
El Alam, Molly B.
Subbiah, Vivek
Taniguchi, Cullen M.
Ludmir, Ethan B.
Lin, Timothy A.
[J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (10) : 2293 - 2294
[45] A Review of Clinical Trials of Tai Chi and Qigong in Older Adults
Rogers, Carol E.
Larkey, Linda K.
Keller, Colleen
[J]. WESTERN JOURNAL OF NURSING RESEARCH, 2009, 31 (02) : 245 - 279
[46] Regulatory considerations on the enrollment of older adults in oncology clinical trials
Raimi-Abraham, Bahijja Tolulope
de Orbe Izquierdo, Maria Silvia
Collignon, Olivier
Cerreta, Frahcesca
[J]. JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (03) : 151 - 153
[47] Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults A Randomized Clinical Trial
Rooks, Daniel
Swan, Therese
Goswami, Budhaditya
Filosa, Lee Anne
Bunte, Ola
Panchaud, Nicolas
Coleman, Laura A.
Miller, Ram R.
Garcia Garayoa, Elisa
Praestgaard, Jens
Perry, Robert G.
Recknor, Chris
Fogarty, Charles M.
Arai, Hidenori
Chen, Liang-Kung
Hashimoto, Jun
Chung, Yoon-Sok
Vissing, John
Laurent, Didier
Petricoul, Olivier
Hemsley, Sarah
Lach-Trifilieff, Estelle
Papanicolaou, Dimitris A.
Roubenoff, Ronenn
[J]. JAMA NETWORK OPEN, 2020, 3 (10) : E2020836
[48] DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH (ICFSR)
Vellas, B.
Fielding, R.
Miller, R.
Rolland, Y.
Bhasin, S.
Magaziner, J.
Bischoff-Ferrari, H.
[J]. JOURNAL OF FRAILTY & AGING, 2014, 3 (04): : 199 - 204
[49] Measuring outcomes of treatment with antiepileptic drugs in clinical trials
Ben-Menachem, Elinor
Sander, Josemir W.
Privitera, Michael
Gilliam, Frank
[J]. EPILEPSY & BEHAVIOR, 2010, 18 (1-2) : 24 - 30
[50] The Gap Between Clinical Trials and the Real World Extrapolating Treatment Effects From Younger to Older Adults
Tinetti, Mary E.
[J]. JAMA INTERNAL MEDICINE, 2014, 174 (03) : 397 - 398

← 1 2 3 4 5 →